CIK 0000949858 · Non-accelerated filer<br>Smaller reporting company
ACHIEVE LIFE SCIENCES, INC.
Sign in to watch- Ticker
- ACHV
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 954343413
- Phone
- 425-686-1500
- Business address
- 22722 29TH DR. SE, SUITE 100, SEATTLE, WA, 98021
- Former names
- ONCOGENEX PHARMACEUTICALS, INC., SONUS PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $175,177
- in 1 filing
Net −$175,177. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-06-06 | KING THOMAS BRAXTON Director | Grant or award · Stock Option (right to buy) | +31,500 | 31,500 | ||
| 2025-06-06 | Duty Stuart Director | Grant or award · Stock Option (right to buy) | +31,500 | 31,500 | ||
| 2025-03-17 | Oki Mark K Chief Financial Officer | Purchase | +10,000 | $2.89 | $29K | 10,000 |
| 2025-03-17 | Stewart Richard Alistair Chieve Executive Officer | Purchase | +10,000 | $2.86 | $29K | 60,876 |
| 2025-01-28 | Wan Jerry Principal Accounting Officer | Grant or award · Performance Restricted Stock Unit (PRSU) | +48,000 | 48,000 | ||
| 2025-01-28 | Xinos Jaime Chief Commercial Officer | Grant or award · Performance Restricted Stock Unit (PRSU) | +100,000 | 100,000 | ||
| 2025-01-28 | JACOBS CINDY President & CMO | Grant or award · Performance Restricted Stock Unit (PRSU) | +130,000 | 130,000 | ||
| 2025-01-13 | Slaoui Kristen B. Director | Grant or award · Stock Option (right to buy) | +47,250 | 47,250 | ||
| 2025-01-13 | Phelan Nancy R. Director | Grant or award · Stock Option (right to buy) | +47,250 | 47,250 | ||
| 2025-01-13 | Stewart Richard Alistair Chieve Executive Officer | Grant or award · Performance Restricted Stock Unit (PRSU) | +157,500 | 157,500 | ||
| 2025-01-13 | Stewart Richard Alistair Chieve Executive Officer | Grant or award · Stock Option (right to buy) | +67,500 | 67,500 | ||
| 2025-01-13 | KING THOMAS BRAXTON Executive Chairman | Grant or award · Performance Restricted Stock Unit (PRSU) | +455,000 | 455,000 | ||
| 2025-01-13 | KING THOMAS BRAXTON Executive Chairman | Grant or award · Stock Option (right to buy) | +195,000 | 195,000 | ||
| 2025-01-13 | Xinos Jaime Chief Commercial Officer | Grant or award · Stock Option (right to buy) | +20,000 | 20,000 | ||
| 2024-12-06 | Xinos Jaime Chief Commercial Officer | Grant or award · Stock Option (right to buy) | +30,000 | 30,000 | ||
| 2024-12-06 | Oki Mark K Chief Financial Officer | Grant or award · Common Stock Options (right to buy) | +72,000 | 72,000 | ||
| 2024-12-06 | Oki Mark K Chief Financial Officer | Grant or award · Performance Restricted Stock Unit (PRSU) | +168,000 | 168,000 | ||
| 2024-08-16 | Wan Jerry Principal Accounting Officer | Grant or award | +2,857 | $3.67 | $10K | 12,664 |
| 2024-08-16 | JACOBS CINDY President & CMO | Grant or award | +2,660 | $3.67 | $10K | 33,214 |
| 2024-08-16 | Bencich John CEO | Grant or award | +5,000 | $3.67 | $18K | 100,636 |
Page 4 of 36 · 715 trades